To study effect of Trikarshika ghanvati in treating gout ( vaatarakta)
- Conditions
- Gout, unspecified. Ayurveda Condition: VATARAKTAM,
- Registration Number
- CTRI/2025/05/087320
- Lead Sponsor
- Shree Saptashrungi Ayurved Mahavidyalaya Kamal nagar Hirawadi Panchvati Nashik
- Brief Summary
Primary Objective -
1.To study the effect of Trikarshika ghanvati in the management of vaatarakta.
Secondary objective-
1.To study the difference of the effect of Febuxostat and Trikarshika ghanvati in the management of vaatarakta.
Other Objective-
1.To review and study the literature of vaatarakta.
2.To review and study the literature of Gout.
Study-Randomised Control Trial
Intervention-
Group A- Trikarshika ghanvati 500 mg bd
Group B- Febuxostat 40 mg bd
Duration of Treatment- 30 days
Initial Assessment 0n 1 st day
Follow up- 15th ,30 th day
Data analysis
Data will be analysed using appropriate statistical methods to compare the effectiveness of intervention on the primary and secondary outcomes.
Ethical Consideration -
The study will be conducted in accordance with Ethical Guidelines and with informed consent from participants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 60
Patients having uric acid level between 6mg/dl to 10mg/dl.
- Amavata (Rheumatoid Arthritis) 2.
- Sandhigata vaata 3.
- With H/O malignancy HIV trauma Cardiac disease Neurological disorders etc associated with gout 4.
- Pregnant women and lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in signs and symptoms of gout. 30 days
- Secondary Outcome Measures
Name Time Method Where trial group stands in comparison with control group in reducing signs and symptoms of gout 18 months
Trial Locations
- Locations (1)
Shree Saptashrungi Ayurved Mahavidyalaya And Hospital
🇮🇳Nashik, MAHARASHTRA, India
Shree Saptashrungi Ayurved Mahavidyalaya And Hospital🇮🇳Nashik, MAHARASHTRA, IndiaDr Divya Shriniwas PogulPrincipal investigator8766573836poguldivya@gmail.com